News & Perspective

Apr 18, 2002

Apr 18, 2002

FDA approves cosmetic use of botulinum toxin

(CIDRAP News) – The Food and Drug Administration (FDA) this week endorsed a widespread cosmetic procedure by approving the use of botulinum toxin type A to temporarily smooth frown lines between the eyebrows.

Sort Results By:

 Sort Results By:

Narrow results by:

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»